StockTipsArenaBeta

BUY Emcure Pharmaceuticals Limited — Motilal Oswal

BUYEmcure Pharmaceuticals Limited

byMotilal OswalHorizon: NA (inferred 1 year)7 Aug 2026via Institutional / Brokerage Research

Entry₹1,936.7Inferred
Target₹2,300
Total upside +18.76%
Stop lossNot given
CMP₹1,926.81h ago
Active-0.51%+19.37%upside left 11 mo left
Follow Motilal Oswal for new calls(61% target hit, 1112 closed calls)Get alertsWatch EMCURE for new buy/sell callsGet alertsSee 6 other Long-term calls on EMCURESee 36 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 5:42 pm IST
16 supporting4 neutral1 opposing
Supports the BUY call (16)

Emcure Pharma: Here's Why ICICI Direct Calls It A High-Conviction 'Buy'

NewsNdtv-Profit·7 Sept · today

(opens in new tab)

Broker’s call: Emcure Pharma (Buy)

NewsHbl·4 Sept · 3d ago

(opens in new tab)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·4 Sept · 3d ago

3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · same horizon·4 Sept · 3d ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·8 Jul · 2mo ago

Neutral / worth noting (4)

Market Trading Guide: Emcure Pharma among 2 stock recommendations for Monday

NewsEt-Markets·6 Sept · yesterday

(opens in new tab)

Coal India, Emcure Pharma, Finolex Cables, GIC, Gulf Oil Lubricants Dividends: Last Day To Buy Shares To Qualify

NewsNdtv-Profit·3 Sept · 4d ago

(opens in new tab)

EMCURE PHARMACEUTICALS L Share Price

NewsGoogle News·25 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.